Amplifying the Migraine Community's Voice in ICER's Value Assessment Process
In an interview with NPC, Lindsay Videnieks, director of the Headache and Migraine Policy Forum, discusses the kind of effort it takes to become involved in the ICER value assessment process, what her organization learned along the way and how ICER’s patient engagement process could be improved.
NPC @ ISPOR Summit 2018: New Approaches to Value Assessment
Join NPC Chief Science Officer and Executive Vice President Robert W. Dubois, MD, PhD, at the ISPOR Summit 2019 on Oct. 19 in Washington, D.C., where Dr. Dubois will speak about “New Approaches to Value Assessment: Towards More Informed Pricing in Healthcare” at 12:45 p.m.
NPC in Specialty Pharmacy Times: Inconsistent Specialty Pharmaceutical Coverage Threatens Care Coordination, Continuity
In his latest column for Specialty Pharmacy Times, NPC President and Chief Executive Officer Dan Leonard explores research published in Health Affairs that sheds light on when and how payers cover specialty medications.